Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction.

@article{Ackerman2005FructoseinducedFL,
  title={Fructose-induced fatty liver disease: hepatic effects of blood pressure and plasma triglyceride reduction.},
  author={Zvi Ackerman and Mor Oron-Herman and Maria Grozovski and Talma Rosenthal and Orit Pappo and Godehard Link and Ben-ami Sela},
  journal={Hypertension},
  year={2005},
  volume={45 5},
  pages={1012-8}
}
The most known risk factor for nonalcoholic fatty liver disease (NAFLD) is the metabolic syndrome. In this study, we characterized changes in liver pathology, hepatic lipid composition, and hepatic iron concentration (HIC) occurring in rats given fructose-enriched diet (FED), with and without therapeutic maneuvers to reduce blood pressure and plasma triglycerides. Rats were given FED or standard rat chow for 5 weeks. Rats on FED were divided into 4 groups: receiving amlodipine (15 mg/kg per day… CONTINUE READING
75 Citations
54 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 75 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 54 references

Therapeutic efficacy of angiotensin 2 receptor antagonist in patients with nonalcoholic steatohepatits

  • S Yokohoma, M Yoneda, +7 authors K. Nakamura
  • Hepatology
  • 2004

Similar Papers

Loading similar papers…